Clinical Trial Update: Protection From Acute Kidney Injury (AKI) With Basis™ Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing Basis treatment for protection from acute kidney injury (AKI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Basis (nicotinamide riboside with pterostilbene)

Snippet

Sponsor: Mayo Clinic | Conditions: AKI | Phase 2 | Status: COMPLETED